---
figid: PMC4727530__nihms-732955-f0002
figlink: /pmc/articles/PMC4727530/figure/F2/
number: Figure 2
caption: 'Examples of commonly occuring cancers driven by specific oncogenic driver
  mutations that result in constitutively activated downstream kinase signaing pathways
  and suppression of the mitochondrial apoptotic pathway. By inhibiting these pathways,
  targeted therapies lead to upregulation of pro-apoptotic BH3-only proteins and/or
  downregulation of pro-survival BCL-2 family proteins, ultimately inducing apoptosis.
  (See references: EGFR (, , , , ), BRAF (, , ), KRAS (), CML (, , ))'
pmcid: PMC4727530
papertitle: 'The BCL-2 family: key mediators of the apoptotic response to targeted
  anti-cancer therapeutics.'
reftext: Aaron N. Hata, et al. Cancer Discov. ;5(5):475-487.
pmc_ranked_result_index: '51152'
pathway_score: 0.8876371
filename: nihms-732955-f0002.jpg
figtitle: 'BCL-2 family: key mediators of the apoptotic response to targeted anti-cancer
  therapeutics'
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4727530__nihms-732955-f0002.html
  '@type': Dataset
  description: 'Examples of commonly occuring cancers driven by specific oncogenic
    driver mutations that result in constitutively activated downstream kinase signaing
    pathways and suppression of the mitochondrial apoptotic pathway. By inhibiting
    these pathways, targeted therapies lead to upregulation of pro-apoptotic BH3-only
    proteins and/or downregulation of pro-survival BCL-2 family proteins, ultimately
    inducing apoptosis. (See references: EGFR (, , , , ), BRAF (, , ), KRAS (), CML
    (, , ))'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCR
  - PIK3CD
  - EGFR
  - PIK3R3
  - BRAF
  - MAPK1
  - PIK3CG
  - MYOD1
  - PIK3R6
  - MCL1
  - BCL2L11
  - MTOR
  - BBC3
  - PIK3CB
  - BAD
  - MAPK3
  - PIK3CA
  - KRAS
  - PIK3R5
  - FOXO3
  - MAP2K1
  - MAP2K2
  - PIK3R4
  - Nilotinib
  - AZD6244
  - Trametinib
  - Dabrafenib
  - Cancer
  - Lung cancer
genes:
- word: CML
  symbol: CML
  source: hgnc_alias_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Pum
  symbol: PUM
  source: hgnc_alias_symbol
  hgnc_symbol: MYOD1
  entrez: '4654'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Mcl-1
  symbol: Mcl-1
  source: hgnc_alias_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: Bim
  symbol: BIM
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Puma
  symbol: PUMA
  source: hgnc_alias_symbol
  hgnc_symbol: BBC3
  entrez: '27113'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: FOXO3A
  symbol: FOXO3A
  source: hgnc_prev_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
chemicals:
- word: Nilotinib
  source: MESH
  identifier: C498826
- word: AZD6244
  source: MESH
  identifier: C517975
- word: Trametinib
  source: MESH
  identifier: C560077
- word: Dabrafenib
  source: MESH
  identifier: C561627
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
